SSAnkang Health
English Español Português العربية
Consult Now
Home Services Hospitals Doctors Treatment & Verification Patient Stories Resources About FAQ Consult Now
EN ES PT AR
Home / Services / Oncology & Cancer Care / Prostate Cancer
Oncology & Cancer Care

Prostate Cancer

Robotic prostatectomy and proton therapy available at top urology centers. Active surveillance protocols for low-risk disease.

2
Treatment Options
4
Recommended Centers
$12,000
Starting From
7-21 days
Typical Wait

Treatment Plans for Prostate Cancer

Compare evidence-based options at top Chinese hospitals — transparent pricing, typical wait, and recovery time.

Proton Beam Therapy

Pencil-beam proton radiotherapy at SPHIC; lower rectal/bladder toxicity than IMRT.

Wait Time
14-21 days
Hospital Stay
5-7 weeks outpatient
Recovery
Outpatient
Estimated Price
Approx. $42,000
View Detailed Introduction — Procedure, Price Comparison & More
Price Comparison: China vs. USA
🇨🇳 China
$38,000
🇺🇸 USA
$125,000+
Save up to $87,000 per treatment
Procedure Steps
1
Pre-op: mpMRI + fiducial marker placement (gold seeds)
2
CT simulation + MRI fusion for treatment planning
3
Pencil-beam scanning proton plan optimization (IMPT)
4
Daily alignment with cone-beam CT
5
Treatment delivery: 20-28 fractions over 4-6 weeks
6
Each session: 15-20 minutes on treatment table
7
Weekly PSA and toxicity assessment
8
Follow-up: PSA every 3 months for 2 years

What is Proton Beam Therapy?

Proton therapy uses the unique physical property of protons (Bragg peak) to deposit maximum radiation dose directly in the tumor while sparing tissue beyond it. For prostate cancer, this means significantly lower radiation dose to the rectum and bladder compared to conventional IMRT.

Why China?

  • SPHIC (Shanghai): One of the world's most advanced proton-heavy ion centers
  • Cost: $38,000-$50,000 vs. $80,000-$150,000 in the US
  • Latest technology: Pencil-beam scanning with motion management

Who is a candidate?

  • Low-to-intermediate risk localized prostate cancer
  • Patients who prioritize bowel/bladder toxicity reduction
  • Re-irradiation of recurrent disease

Outcomes

5-year biochemical control: 90-95% for favorable-risk. Grade 3+ rectal toxicity: <1% (vs 3-5% with IMRT).

Book Free Consultation WhatsApp

Prices are indicative ranges in USD based on partner hospital published rates. Final quote depends on your medical records and selected hospital — request a free personalized estimate.

Why China for Prostate Cancer

Robotic RALP and proton beam (SPHIC) at 40-50% Western cost; 4-arm Da Vinci centers in Beijing and Shanghai.

Recommended Hospitals for Prostate Cancer

Hand-picked by case volume, outcomes, and international patient experience.

#1
Shanghai Proton and Heavy Ion Center
Shanghai

Shanghai Proton and Heavy Ion Center

ISO 9001
200
View Hospital
#2
Peking Union Medical College Hospital
Beijing

Peking Union Medical College Hospital

JCI HIMSS Stage 7 ISO 9001
2,000
View Hospital
#3
Zhongshan Hospital, Fudan University
Shanghai

Zhongshan Hospital, Fudan University

JCI HIMSS Stage 7 ISO 9001
2,400
View Hospital
#4
Sun Yat-Sen University Cancer Center
Guangzhou

Sun Yat-Sen University Cancer Center

JCI ISO 9001
1,500
View Hospital

About Prostate Cancer

Common Symptoms
  • Often asymptomatic early
  • Urinary frequency
  • Hematuria
  • Bone pain (advanced)
  • Erectile dysfunction
Common Causes
  • Age >50
  • Family history
  • BRCA mutations
  • African ancestry
Diagnostic Methods
  • PSA test
  • Multiparametric prostate MRI
  • MRI-guided biopsy
  • PSMA PET-CT

Evidence & Reference Standards

Our oncology pathways align with internationally recognized cancer-care guidelines:

NCCN · United States
Clinical Practice Guidelines in Oncology
Tumor-specific staging, treatment sequencing and biomarker testing recommendations applied to every oncology plan we coordinate.
NCI · National Cancer Institute
PDQ Cancer Information Summaries
Peer-reviewed evidence on prognosis, supportive care and emerging targeted/immunotherapy options reviewed during multi-disciplinary tumor board.
ASCO · United States
ASCO Guidelines
Quality-of-care indicators for systemic therapy, palliative integration and survivorship that frame our follow-up schedule.
ESMO · Europe
ESMO Clinical Practice Guidelines
European reference for staging, molecular testing and second-line therapy — used to cross-check Chinese-hospital protocols against international standards.

SSAnkang Health is a medical-tourism coordination service; clinical procedures are performed by JCI-accredited Chinese hospitals. This page is for general information and does not constitute medical advice.

Related Conditions

Keytruda (Pembrolizumab) PD-1 Immunotherapy
Authentic Merck-supplied Keytruda (pembrolizumab) at China's top oncology center…
Lung Cancer
The leading cancer killer worldwide. China performs more lung-cancer surgeries t…
Breast Cancer
The most common cancer in women globally. China leads in breast-conserving surge…
Liver Cancer (HCC)
China accounts for ~50% of global HCC cases. Top centers offer hepatectomy, TACE…